Investor profile
Kurma Partners has backed 26 European tech companies across 34 funding rounds between 2016 and 2026, joining rounds totalling €693M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 2 | €153M |
| Amolyt Pharma | France | 1 | €129M |
| Coave Therapeutics | France | 2 | €53M |
| Sunrise | Belgium | 3 | €48M |
| Vivet Therapeutics | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |
| Coave Therapeutics |
| 1 |
| €38M |
| Stilla Technologies | France | 1 | €31M |
| STAT-Diagnostica | Spain | 1 | €25M |
| Ganymed Robotics | France | 1 | €21M |
| Memo Therapeutics | Switzerland | 1 | €20M |
| Imcheck Therapeutics | France | 1 | €20M |
| Synendos Therapeutics | Switzerland | 1 | €19M |
| tacalyx | Germany | 2 | €18M |
| Deepull | Spain | 2 | €17M |
| PathoQuest | France | 1 | €15M |
| Kiro | France | 1 | €14M |
| Raidium | France | 1 | €13M |
| Sensome | France | 2 | €13M |
| Damae Medical | France | 2 | €7.0M |
| Charles.co | France | 1 | €7.0M |
| Ermium Therapeutics | France | 1 | €6.3M |
| Spotlight Medical | France | 1 | €6.2M |
| Omnidoc | France | 1 | €6.0M |
| CardioLogs | France | 1 | €5.4M |
| Poppins | France | 1 | €5.0M |
| Arkhn | France | 1 | €4.0M |
| Corlieve Therapeutics | France | 1 | €0 |
| Series A |
| €32M |
| 2025-01 |
| Stilla Technologies | Other | €31M | 2021-11 |
| STAT-Diagnostica | Series C | €25M | 2016-04 |
| Sunrise | Other | €25M | 2025-09 |
| Coave Therapeutics | Series B | €21M | 2021-07 |
| Ganymed Robotics | Series B | €21M | 2022-07 |
| Memo Therapeutics | Series C | €20M | 2024-05 |
